ANESTHESIA GASES MARKET ANALYSIS

Anesthesia Gases Market, By Product Type (Anesthesia Gases and Vaporizer Devices), By Anesthesia Gases (Desflurane, Sevoflurane, Isoflurane, Nitrous Oxide, and Other Anesthesia Gases), By End User (Hospital and Ambulatory Surgical Centers), and By Geography (North America, Europe, Asia Pacific, Middle East and Africa, and Latin America)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Published In : Jan 2023
Code : CMI5499
Pages :163
Formats :
Excel and PDF
Industry : Pharmaceutical

Market News

Global Anesthesia Gases Market: Key Developments

In September 2019, Baxter announces the acquisition of Cheetah Medical to expand specialized patient monitoring portfolio.

In July 2019, AbbVie acquired Seattle (US)-based Mavupharma, a biopharmaceutical company focused on novel approaches to target the STING (STimulator of INterferon Genes) pathway for the treatment of cancer.

In March 2019, Adventist Health and GE Healthcare announced their collaboration that may help transform healthcare delivery and patient experience across the 21-hospital system in California, Oregon, and Hawaii.

In November 2018, Sedana Medical received market approval for AnaConDa from the Ministry of Health, Labour, and Welfare (MHLW) in Japan. AnaConDa is used in the administration of volatile anesthetics for mechanically ventilated patients in intensive care.

In March 2018, Baxter and BioMérieux collaborated to improve identification and treatment of acute kidney injury.